NCT04316793 is a NA clinical trial of Dry needling in Trigger Point Pain, Myofascial, sponsored by Université de Sherbrooke.

Who is sponsoring NCT04316793?

NCT04316793 is sponsored by Université de Sherbrooke.

What drugs are being tested in NCT04316793?

Interventions in NCT04316793: Dry needling, Sham needling (SN).

What condition does NCT04316793 study?

NCT04316793 studies Trigger Point Pain, Myofascial, Chronic Shoulder Pain.

Is NCT04316793 still recruiting?

NCT04316793 is currently completed. Last updated 20 March 2020.

Last reviewed 2020-03-20 · How we verify

NCT04316793

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Dry Needling When Applied to the Infraspinatus Muscle in People With Chronic Shoulder Pain

Completed NA Last updated 20 March 2020

What this trial tests

NA trial testing Dry needling in Trigger Point Pain, Myofascial in 21 participants. Completed in 20 December 2019.

Timeline

3 March 2019

Primary endpoint
20 December 2019

20 December 2019

Quick facts

Lead sponsor	Université de Sherbrooke
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	21
Start date	3 March 2019
Primary completion	20 December 2019
Estimated completion	20 December 2019
Sites	1 location across Canada

Drugs / interventions tested

Dry needling
Sham needling (SN)

Conditions studied

Trigger Point Pain, Myofascial — all drugs for Trigger Point Pain, Myofascial →
Chronic Shoulder Pain — all drugs for Chronic Shoulder Pain →

Sponsor

Université de Sherbrooke — full company profile →

Who can join

Adults 18 to 65, any sex, with Trigger Point Pain, Myofascial or Chronic Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Up to 77% of patients with chronic shoulder pain have a trigger point (TrP) in the infraspinatus muscle. These TrPs can lead to pain, limitation of activities and reduced quality of life. Dry needling (DN) is gaining popularity as a treatment for TrPs in physiotherapy. However, its clinical effects remain poorly understood mechanistically and its neurophysiological effects little studied. The primary objective of this study is to determine the feasibility of a larger scale study. The secondary objective of this study is to to explore the immediate neurophysiological, biomechanical and clinical effects of DN and sham needling when applied to TrP of the infraspinatus muscle in people with chronic non-traumatic shoulder pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Neurophysiological and psychophysical effects of dry versus sham needling of the infraspinatus muscle in patients with chronic shoulder pain: a randomized feasibility study.
Laramée A, Léonard G, Morin M, Roch M, et al · · 2021 · cited 7× · PMID 34663474 · DOI 10.1186/s40945-021-00118-x

Verify or expand the search:

Other trials of Dry needling

Trials testing the same drug.

NCT07309874 — Effect of Ultrasound-Guided Dry Needling Targeting Rectus Capitus Posterior Major on Individuals With Headaches · NA · recruiting
NCT07474948 — Effects of Dry Needling the Calf Muscles on Biomechanics and Muscle Function in Individuals With Restricted Dorsiflexion · NA · active not recruiting
NCT07345793 — Effects of Minimally Invasive Techniques in Healthy and Chronic Cervical Pain Individuals · NA · completed
NCT07321483 — Reflex Therapy of Temporomandibular Dysfunctions · NA · recruiting
NCT06891963 — Transcutaneous Electrical Nerve Stimulation Versus Dry Needling in Non Specific Chronic Neck Pain · NA · not yet recruiting

Other recruiting trials for Trigger Point Pain, Myofascial

Currently open trials in the same condition.

NCT07138807 — Effect of MET vs Neck Calliet Exercises on Neck Pain and Disability in Nurses · NA · recruiting
NCT06986707 — Strain Counterstrain Technique and Graston Technqiue on Quadratus Lumborum Trigger Points · NA · recruiting
NCT06986317 — Effectiveness of Positional Release Techniques and Graston Technique In Trigger Point · NA · recruiting
NCT06664359 — Safe Zone in Trigger Point Injection · recruiting
NCT06316583 — Clinical Study on Dry Needling for Primary Dysmenorrhea and Its Preliminary Correlation With Acupoints · NA · recruiting

Other Université de Sherbrooke trials

Trials by the same sponsor.

NCT07524764 — Female Reproductive Health in Canadian Armed Forces · not yet recruiting
NCT07511842 — REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes · NA · recruiting
NCT07360587 — Thyroid Artery Embolization for the Treatment of Compressive Goiters. · NA · recruiting
NCT07396857 — The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting · NA · recruiting
NCT07122531 — Recovery With Exogenous Ketones and Antipsychotics · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04316793 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université de Sherbrooke
Last refreshed: 20 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04316793.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing